{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:41:48Z","timestamp":1791380508474,"version":"4.3.3"},"reference-count":27,"publisher":"MedWorks Media","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:p>Kleine-Levin Syndrome (KLS) is a rare, neurological disorder characterized by episodes of hypersomnia, cognitive impairment, and behavioral abnormalities. The etiology of KLS remains unclear, and treatment responses are highly variable. This report describes a 22-year longitudinal experience with a 40-year-old male diagnosed with KLS at 15 years of age. Treatment trials of all standard KLS medications (lithium, valproic acid, selective serotonin reuptake inhibitors, modafinil) yielded no benefit in attenuating or preventing episodes. Following the onset of overlapping an acute KLS exacerbation and catatonia-like symptoms, the patient\u2019s episode was shortened after a trial of intravenous (IV) lorazepam. This response was consistently reproduced, with episodes resolving after approximately 5\u20137 days of IV lorazepam administration. Notably, the frequency of episodes increased after the patient contracted COVID-19 despite the continued efficacy of IV lorazepam in reducing episode duration. This case highlights the potential utility of IV lorazepam in terminating acute KLS episodes. While short-term outcomes were favorable, the observed increase in episode frequency underscores the need to assess the risks of chronic benzodiazepine exposure, including receptor downregulation and tolerance. These findings support the use of lorazepam in acute KLS management but emphasize caution regarding long-term reliance and encourage further mechanistic and therapeutic research into episodic hypersomnia and benzodiazepine responsiveness. Psychopharmacology Bulletin. 2026;56(1):162\u2013169.<\/jats:p>","DOI":"10.64719\/pb.15441","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:38:16Z","timestamp":1767976696000},"page":"162-169","source":"Crossref","is-referenced-by-count":0,"title":["The Use of Lorazepam for Acute Episodes in a Patient with Kleine-Levin Syndrome: A Longitudinal Case Report"],"prefix":"10.64719","volume":"56","author":[{"given":"Michael","family":"Hamper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rancurello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Arnulf I, Groos E, Dodet P. Kleine-Levin syndrome: a neuropsychiatric disorder. Rev Neurol (Paris). 2018;174(4):216\u2013227. doi: 10.1016\/j.neurol.2018.03.005.","DOI":"10.1016\/j.neurol.2018.03.005"},{"key":"ref2","unstructured":"American Academy of Sleep Medicine. 2023 International Classification of Sleep Disorders. text revision, American Academy of Sleep Medicine."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Arnulf I, Zeitzer JM, File J, Farber N, Mignot E. Brain. 2005;128(Pt 12):2763\u20132776. doi: 10.1093\/brain\/awh620. Kleine-Levin syndrome: a systematic review of 186 cases in the literature.","DOI":"10.1093\/brain\/awh620"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Leu-Semenescu S, Le Corvec T, Groos E, Lavault S, Golmard JL, Arnulf I. Lithium therapy in Kleine-Levin syndrome: an open-label, controlled study in 130 patients. Neurology. 2015;85(19):1655\u20131662. doi: 10.1212\/WNL.0000000000002104.","DOI":"10.1212\/WNL.0000000000002104"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Oliveira MM, Conti C, Saconato H, Fernandes do Prado G. Pharmacological treatment for Kleine-Levin Syndrome. Cochrane Database Syst Rev. 2009;(2):CD006685. doi: 10.1002\/14651858.CD006685.pub2. Published 2009 Apr 15.","DOI":"10.1002\/14651858.CD006685.pub2"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Trotti LM, Bliwise DL, Rye DB. J Clin Sleep Med. 2014;10(4):457\u2013458. doi: 10.5664\/jcsm.3634. Further experience using clarithromycin in patients with Kleine-Levin syndrome. Published 2014 Apr 15.","DOI":"10.5664\/jcsm.3634"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"L\u00e9otard A, Groos E, Chaumereuil C et al. IV steroids during long episodes of Kleine-Levin syndrome. Neurology. 2018;90(17):e1488\u2013e1492. doi: 10.1212\/WNL.0000000000005349.","DOI":"10.1212\/WNL.0000000000005349"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Arnulf I, Lin L, Gadoth N et al. Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol. 2008;63(4):482\u2013493. doi: 10.1002\/ana.21333.","DOI":"10.1002\/ana.21333"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Dauvilliers Y, Arnulf I, Foldvary-Schaefer N et al. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study. Lancet Neurol. 2022;21(1):53\u201365. doi: 10.1016\/S1474-4422(21)00368-9.","DOI":"10.1016\/S1474-4422(21)00368-9"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Hamper M, Cassano P, Lombard J. Treatment of Kleine-Levin syndrome with intranasal photobiomodulation and methylene blue. Cureus. 2021;13(10):e18596. doi: 10.7759\/cureus.18596. Published 2021 Oct 8.","DOI":"10.7759\/cureus.18596"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Arnulf I, Dodet P, Leu-Semenescu S, Maranci JB. Idiopathic hypersomnia and Kleine-Levin syndrome. Rev Neurol (Paris). 2023;179(7):741\u2013754. doi: 10.1016\/j.neurol.2023.08.010.","DOI":"10.1016\/j.neurol.2023.08.010"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Lavault S, Golmard JL, Groos E et al. Kleine-Levin syndrome in 120 patients: differential diagnosis and long episodes. Ann Neurol. 2015;77(3):529\u2013540. doi: 10.1002\/ana.24350.","DOI":"10.1002\/ana.24350"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Ambati A, Hillary R, Leu-Semenescu S et al. Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci. Proc Natl Acad Sci U S A. 2021;118(12):e2005753118. doi: 10.1073\/pnas.2005753118.","DOI":"10.1073\/pnas.2005753118"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Hamper M, Schmidt-Kastner R. Sleep disorder Kleine-Levin syndrome (KLS) joins the list of polygenic brain disorders associated with obstetric complications. Cell Mol Neurobiol. 2023;43(7):3393\u20133403. doi: 10.1007\/s10571-023-01391-z.","DOI":"10.1007\/s10571-023-01391-z"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Dauvilliers Y, Mayer G, Lecendreux M et al. Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology. 2002;59(11):1739\u20131745. doi: 10.1212\/01.wnl.0000036605.89977.d0.","DOI":"10.1212\/01.wnl.0000036605.89977.d0"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"H\u00e9dou J, Cederberg KL, Ambati A et al. Proteomic biomarkers of Kleine-Levin syndrome. Sleep. 2022;45(9):zsac097. doi: 10.1093\/sleep\/zsac097.","DOI":"10.1093\/sleep\/zsac097"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Uguccioni G, Lavault S, Chaumereuil C, Golmard JL, Gagnon JF, Arnulf I. Long-term cognitive impairment in Kleine-Levin syndrome. Sleep. 2016;39(2):429\u2013438. doi: 10.5665\/sleep.5458. Published 2016 Feb 1.","DOI":"10.5665\/sleep.5458"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Ortiz JF, Argudo JM, Y\u00e9pez M et al. Neuroimaging in the rare sleep disorder of Kleine-Levin syndrome: a systematic review. Clocks Sleep. 2022;4(2):287\u2013299. doi: 10.3390\/clockssleep4020025. Published 2022 May 31.","DOI":"10.3390\/clockssleep4020025"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Groos E, Chaumereuil C, Flamand M et al. Emerging psychiatric disorders in Kleine-Levin syndrome. J Sleep Res. 2018;27(5):e12690. doi: 10.1111\/jsr.12690.","DOI":"10.1111\/jsr.12690"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Maben A, Mahato K, Sharma A et al. A patient with Kleine-Levin syndrome experiencing new-onset psychosis complicated by catatonia: a case report. Psychiatry Research Case Reports. 2023;2(2) doi: 10.1016\/j.psycr.2023.100162.","DOI":"10.1016\/j.psycr.2023.100162"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Northoff G, Steinke R, Czcervenka C et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry. 1999;67(4):445\u2013450. doi: 10.1136\/jnnp.67.4.445.","DOI":"10.1136\/jnnp.67.4.445"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Beach SR, Gomez-Bernal F, Huffman JC, Fricchione GL. Alternative treatment strategies for catatonia: a systematic review. Gen Hosp Psychiatry. 2017;48:1\u201319. doi: 10.1016\/j.genhosppsych.2017.06.011.","DOI":"10.1016\/j.genhosppsych.2017.06.011"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Northoff G. What catatonia can tell us about \u201ctop-down modulation\u201d: a neuropsychiatric hypothesis. Behav Brain Sci. 2002;25(5):555\u2013604. doi: 10.1017\/s0140525x02000109.","DOI":"10.1017\/s0140525x02000109"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Rogers JP, Pollak TA, Blackman G, David AS. Catatonia and the immune system: a review. Lancet Psychiatry. 2019;6(7):620\u2013630. doi: 10.1016\/S2215-0366(19)30190-7.","DOI":"10.1016\/S2215-0366(19)30190-7"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Pelzer AC, van der Heijden FM, den Boer E. Systematic review of catatonia treatment. Neuropsychiatr Dis Treat. 2018;14:317\u2013326. doi: 10.2147\/NDT.S147897. Published 2018 Jan 17.","DOI":"10.2147\/NDT.S147897"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Ameer B, Greenblatt DJ. Lorazepam: a review of its clinical pharmacological properties and therapeutic uses. Drugs. 1981;21(3):162\u2013200. doi: 10.2165\/00003495-198121030-00001.","DOI":"10.2165\/00003495-198121030-00001"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Little HJ, Nutt DJ, Taylor SC. Kindling and withdrawal changes at the benzodiazepine receptor. J Psychopharmacol. 1987;1(1):35\u201346. doi: 10.1177\/026988118700100108.","DOI":"10.1177\/026988118700100108"}],"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:36:29Z","timestamp":1791315389000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/the-use-of-lorazepam-for-acute-episodes-in-a-patient-with-kleine-levin-syndrome-a-longitudinal-case-report\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.15441","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]}}}